Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immune Pharmaceuticals Inc (EPCT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immune Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1208261.
Total stock buying since 2014: $1,738,608.
Total stock sales since 2014: $300.
Total stock option exercises since 2014: $7,418.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 0 | $0 | 75,000 | $300 | 0 | $0 |
| 2018 | 75,000 | $18,875 | 0 | $0 | 0 | $0 |
| 2017 | 76,503 | $14,229 | 0 | $0 | 0 | $0 |
| 2016 | 2,730,922 | $1,160,662 | 0 | $0 | 185,473 | $7,418 |
| 2015 | 419,669 | $448,842 | 0 | $0 | 0 | $0 |
| 2014 | 38,400 | $96,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-02 | 0 | $0 | 75,000 | $300 | 0 | $0 |
| 2018-05 | 75,000 | $18,875 | 0 | $0 | 0 | $0 |
| 2017-01 | 76,503 | $14,229 | 0 | $0 | 0 | $0 |
| 2016-12 | 161,377 | $30,016 | 0 | $0 | 0 | $0 |
| 2016-10 | 0 | $0 | 0 | $0 | 185,473 | $7,418 |
| 2016-08 | 2,381,945 | $1,006,250 | 0 | $0 | 0 | $0 |
| 2016-01 | 187,600 | $124,396 | 0 | $0 | 0 | $0 |
| 2015-12 | 215,400 | $167,050 | 0 | $0 | 0 | $0 |
| 2015-10 | 96,700 | $124,641 | 0 | $0 | 0 | $0 |
| 2015-09 | 107,569 | $157,151 | 0 | $0 | 0 | $0 |
| 2014-11 | 38,400 | $96,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-02-03 | Fiorino Anthony S. (Director) | Sale | 75,000 | .00 | 300 |
| 2018-05-22 | Fiorino Anthony S. (Chief Medical Officer and COO) | Buy | 25,000 | .24 | 5,975 |
| 2018-05-17 | Fiorino Anthony S. (Chief Medical Officer and COO) | Buy | 50,000 | .26 | 12,900 |
| 2017-01-04 | Kazado Daniel | Buy | 76,503 | .19 | 14,229 |
| 2016-12-16 | Kazado Daniel | Buy | 161,377 | .19 | 30,016 |
| 2016-10-06 | Teper Daniel Gedeon (CEO) | Option Ex | 185,473 | .04 | 7,418 |
| 2016-08-04 | Luchi Monica E. (EVP & CMO) | Buy | 777,778 | .45 | 350,000 |
| 2016-08-04 | Kazado Daniel | Buy | 666,667 | .45 | 300,000 |
| 2016-08-04 | Teper Daniel Gedeon (CEO) | Buy | 937,500 | .38 | 356,250 |
| 2016-01-26 | Teper Daniel Gedeon (CEO) | Buy | 42,000 | .59 | 24,822 |
| 2016-01-19 | Teper Daniel Gedeon (CEO) | Buy | 44,200 | .57 | 25,017 |
| 2016-01-12 | Teper Daniel Gedeon (CEO) | Buy | 39,400 | .62 | 24,585 |
| 2016-01-05 | Teper Daniel Gedeon (CEO) | Buy | 62,000 | .81 | 49,972 |
| 2015-12-07 | Kazado Daniel | Buy | 150,000 | .78 | 117,150 |
| 2015-12-07 | Teper Daniel Gedeon (CEO) | Buy | 65,400 | .76 | 49,900 |
| 2015-10-26 | Teper Daniel Gedeon (CEO) | Buy | 18,400 | 1.36 | 25,005 |
| 2015-10-19 | Teper Daniel Gedeon (CEO) | Buy | 18,600 | 1.34 | 24,998 |
| 2015-10-12 | Teper Daniel Gedeon (CEO) | Buy | 19,000 | 1.30 | 24,700 |
| 2015-10-05 | Teper Daniel Gedeon (CEO) | Buy | 40,700 | 1.23 | 49,938 |
| 2015-09-14 | Kazado Daniel | Buy | 50,000 | 1.47 | 73,500 |
| 2015-09-14 | Azria Rene Pierre | Buy | 50,000 | 1.48 | 73,850 |
| 2015-09-01 | Teper Daniel Gedeon (CEO) | Buy | 7,569 | 1.29 | 9,801 |
| 2014-11-26 | Kazado Daniel | Buy | 8,000 | 2.50 | 20,000 |
| 2014-11-26 | Berdugo Gad | Buy | 8,000 | 2.50 | 20,000 |
| 2014-11-26 | Durrant Cameron | Buy | 4,000 | 2.50 | 10,000 |
| 2014-11-26 | Stancic Ana | Buy | 8,000 | 2.50 | 20,000 |
| 2014-11-26 | Sidransky David | Buy | 10,400 | 2.50 | 26,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of EPCT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immune Pharmaceuticals Inc (symbol EPCT, CIK number 1208261) see the Securities and Exchange Commission (SEC) website.